Literature DB >> 18346625

The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study.

Christian Schneider1, Berthold Schneider, Juergen Hanisch, Robbert van Haselen.   

Abstract

OBJECTIVES: To assess the use, effectiveness and safety of a homoeopathic preparation (Traumeel) compared with conventional therapies in the treatment of trauma and injuries.
METHODS: Multi-centre, prospective, comparative observational cohort study of patients with various musculoskeletal injuries. German physicians who were using homoeopathy in addition to conventional medicine included patients. Patients treated with Traumeel were compared with patients managed conventionally. The primary outcome measure was the rate of resolution of the principal symptoms (i.e. pain and inflammatory symptoms) at the end of therapy.
RESULTS: Sixty-nine Traumeel treated and 64 conventionally treated patients fitted the selection criteria. The most common diagnoses were acute injuries (sprains, strains, contusions, etc.) of the ankles, knees and hands. There were no significant differences between demographic and anamnestic baseline characteristics of both groups. Complete resolution of the principal symptom at the end of therapy occurred in 41 (59.4%) patients in the homoeopathy group versus 37 (57.8%) patients in the conventional group. No adverse events were reported in the Traumeel group compared to six adverse events (6.3%) in the conventional group. Physician-assessed tolerability was significantly better in the Traumeel group (P=0.001).
CONCLUSION: Traumeel is as effective as conventional medicines in the management of mild to moderate injuries in this population. Traumeel was safe in use and judged by physicians to be better tolerated than conventional medicines. This study contributes to the case for a broad clinical effectiveness of Traumeel in the treatment of acute injuries and trauma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18346625     DOI: 10.1016/j.ctim.2007.04.004

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  7 in total

1.  The Integrated Treatment for Chronic Pain and Anxiety in a Patient with Breast Implant Illness Symptoms: A Case Report.

Authors:  Asmita Patel; Kathryn Blackmore; Robyn Carruthers
Journal:  Integr Med (Encinitas)       Date:  2020-08

2.  Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries.

Authors:  Christian Schneider
Journal:  Int J Gen Med       Date:  2011-03-25

3.  Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non-inferiority trial.

Authors:  C González de Vega; C Speed; B Wolfarth; J González
Journal:  Int J Clin Pract       Date:  2013-07-25       Impact factor: 2.503

Review 4.  Acupuncture for ankle sprain: systematic review and meta-analysis.

Authors:  Jimin Park; Seokyung Hahn; Ji-Yeun Park; Hi-Joon Park; Hyangsook Lee
Journal:  BMC Complement Altern Med       Date:  2013-03-04       Impact factor: 3.659

5.  A Homeopathic Arnica Patch for the Relief of Cellulitis-derived Pain and Numbness in the Hand.

Authors:  Elisabeth Barkey; Marietta Kaszkin-Bettag
Journal:  Glob Adv Health Med       Date:  2012-05

6.  A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol.

Authors:  Luc Vanden Bossche; Guy Vanderstraeten
Journal:  BMC Musculoskelet Disord       Date:  2015-02-04       Impact factor: 2.362

7.  Intramuscular Injection of Combined Calf Blood Compound (CFC) and Homeopathic Drug Tr14 Accelerates Muscle Regeneration In Vivo.

Authors:  Patrick Belikan; Lisa Nauth; Lars-Christopher Färber; Frédéric Abel; Eva Langendorf; Philipp Drees; Pol Maria Rommens; Ulrike Ritz; Stefan G Mattyasovszky
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.